180
Participants
Start Date
December 13, 2019
Primary Completion Date
June 30, 2025
Study Completion Date
May 31, 2028
Tumor and Blood sample collection
"This is a non-interventional protocol and does not provide study drug or specific requirements for how the patients should be treated.~Nevertheless, patients participating in T-DXd trials included in this study are those who were randomized to receive T-DXd.~Tumor sample and blood sample will be collected within the framework of HER2-Predict Study"
Hospital Universitario de Jerez, Jerez de la Frontera
Hospital La Paz, Madrid
Hospital Universitario Virgen de la Arrixaca, Murcia
Hospital Universitario de Canarias, Santa Cruz de Tenerife
Instituto Valenciano de Oncología (IVO), Valencia
ICO Badalona, Badalona
H.Univ. Arnau de Vilanova de Lleida, Lleida
Hospital Virgen de Macarena, Seville
Hospital Universitari Vall d' Hebron, Barcelona
ICO Hospitalet, Barcelona
Hospital Universitario 12 de octubre, Madrid
Hospital Virgen de la Victoria, Málaga
Hospital Universitario Virgen del Rocio, Seville
Hospital del Mar, Barcelona
Hospital Clínic de Barcelona, Barcelona
Collaborators (1)
Daiichi Sankyo
INDUSTRY
SOLTI Breast Cancer Research Group
OTHER